Company Genafarm S.r.l. with Fiscal Code 14576802
recorded a turnover of 2024 of
103.461,
with a net profit of
315
and having an average number of employees of
2.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Genafarm S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
59.349
58.945
53.919
52.726
51.694
59.682
70.245
71.376
86.882
103.461
Total Income - EUR
59.366
59.234
53.921
52.866
52.018
59.718
70.373
71.377
86.884
103.449
Total Expenses - EUR
54.700
56.329
56.456
53.111
53.379
59.516
70.413
70.073
87.866
101.063
Gross Profit/Loss - EUR
4.666
2.905
-2.535
-245
-1.361
202
-39
1.304
-982
2.385
Net Profit/Loss - EUR
3.920
2.313
-3.074
-772
-1.881
-351
-541
590
-1.851
315
Employees
4
3
0
3
3
3
3
2
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 19.8%, from 86.882 euro in the year 2023, to 103.461 euro in 2024.
The Net Profit increased by 315 euro, from 0 euro in 2023, to 315 in the last year.
Check the financial reports for the company - Genafarm S.r.l.
Financial Rating - GENAFARM S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Genafarm S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Genafarm S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Genafarm S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
72.294 euro in 2024 which includes Inventories of
5.556 euro, Receivables of
23.261 euro and cash availability of
43.477 euro.
The company's Equity was valued at
-10.262 euro, while total Liabilities amounted to
82.955 euro.
Equity increased by 315 euro, from -10.637 euro in 2023, to -10.262 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Genafarm S.r.l.